Transmedics Group Inc’s recently made public that its Chief Commercial Officer Khayal Tamer I unloaded Company’s shares for reported $0.13 million on Nov 11 ’24. In the deal valued at $90.04 per share,1,458 shares were sold. As a result of this transaction, Khayal Tamer I now holds 20,843 shares worth roughly $1.68 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Basile Edward M sold 6,750 shares, generating $563,994 in total proceeds. Upon selling the shares at $83.55, the Director now owns 732 shares.
Before that, Khayal Tamer I sold 1,083 shares. Transmedics Group Inc shares valued at $89,499 were divested by the Chief Commercial Officer at a price of $82.64 per share. As a result of the transaction, Khayal Tamer I now holds 20,843 shares, worth roughly $1.68 million.
Oppenheimer reiterated its Transmedics Group Inc [TMDX] rating to an Outperform in a research note published on October 29, 2024; the price target was $125. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in late October has reiterated a ‘”a Buy”‘ rating for it. Robert W. Baird began covering TMDX with “an Outperform” recommendation on September 24, 2024. Needham started covering the stock on August 21, 2024. It rated TMDX as “a Buy”.
Price Performance Review of TMDX
On Friday, Transmedics Group Inc [NASDAQ:TMDX] saw its stock fall -8.92% to $80.48. Over the last five days, the stock has lost -6.40%. Transmedics Group Inc shares have risen nearly 1.96% since the year began. Nevertheless, the stocks have risen 22.70% over the past one year. While a 52-week high of $177.37 was reached on 08/23/24, a 52-week low of $63.85 was recorded on 03/25/24. SMA at 50 days reached $125.63, while 200 days put it at $122.38.
Levels Of Support And Resistance For TMDX Stock
The 24-hour chart illustrates a support level at 77.38, which if violated will result in even more drops to 74.29. On the upside, there is a resistance level at 86.25. A further resistance level may holdings at 92.03. The Relative Strength Index (RSI) on the 14-day chart is 27.30, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.28, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bearish at 96.94%. Stochastics %K at 14.09% indicates the stock is a buying.
How much short interest is there in Transmedics Group Inc?
A steep rise in short interest was recorded in Transmedics Group Inc stocks on 2024-10-31, growing by 2.41 million shares to a total of 8.43 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 6.02 million shares. There was a rise of 28.6%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 06, 2024 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $161 price target.
